Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mayne Pharma Group ( (AU:MYX) ) has issued an update.
Mitsubishi UFJ Financial Group, Inc. has become a substantial holder in Mayne Pharma Group Limited, acquiring a significant voting power of 5.05% through its relevant interest in various securities. This acquisition highlights Mitsubishi UFJ Financial Group’s strategic positioning and influence in the financial sector, potentially impacting Mayne Pharma’s shareholder dynamics and market operations.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 933,152
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$407.9M
Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.